Table 3 Procedure-related complications and 30-day outcomes

 Immediate 72 h procedural mortality

0.9

0.3

2.82 (0.55 14.60)

1.42 (0.21–9.70)

 MVI ≥ II post op

2.7

2.5

1.05 (0.50–2.19)

0.70 (0.28–1.73)

 Wound infection

1.1

1.7

0.67 (0.24–1.85)

0.28 (0.06–1.38)

 Pericardial tamponade

3.6

2.4

1.54 (0.77–3.11)

1.48 (0.58–3.77)

 AV block grade III

6.3

5.4

1.17 (0.71–1.93)

0.98 (0.54–1.81)

 Pneumonia

5.1

3.5

1.47 (0.82–2.62)

1.22 (0.59–2.54)

 Pneumothorax

0.6

1.4

0.42 (0.11–1.58)

0.60 (0.15–2.48)

 Pleural effusion

1.7

2.7

0.63 (0.27–1.43)

0.34 (0.12–0.99)

 AF

16.9

15.7

1.01 (0.79–1.50)

1.05 (0.71–1.55)

 Death

3.6

2.0

1.80 (0.87–3.75)

1.16 (0.45–2.96)

  Cardiovascular death

1.9

1.7

1.12 (0.46–2.72)

0.73 (0.24–2.24)

  Non-CV death

1.7

0.3

5.12 (1.10–23.78)

5.00 (0.52–48.28)

 Stroke

3.6

3.4

1.07 (0.56–2.02)

0.91 (0.43–1.89)

 Acute renal failure

6.3

5.1

1.30 (0.78–2.17)

0.97 (0.49–1.91)

 Myocardial infarction

0.4

0.7

0.56 (0.10–3.06)

0.66 (0.11–4.15)

 Pacemaker implantation

6.8

6.3

1.10 (0.68–1.77)

0.91 (0.51–1.60)

 Re- MV surgery

0.6

0.5

1.12 (0.22–5.58)

0.97 (0.17–5.47)